Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin®-conjugated PLGA-PEG nanoparticles for drug delivery-Reference-Cited by-同舟云学术

Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin®-conjugated PLGA-PEG nanoparticles for drug delivery

Published:2018-02 Issue: Volume:162 Page:271-278
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Badkas Apurva,Frank Evan,Zhou Zilan,Jafari Mina,Chandra Harish,Sriram Vishnu,Lee Joo-Youp,Yadav Jagjit S.

Funder

College of Medicine Dean’s Planning Grant

Marlene Harris-Ride Cincinnati Breast Cancer Foundation

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference39 articles.

1. Active targeting schemes for nanoparticle systems in cancer therapeutics;Byrne;Adv. Drug Deliv. Rev.,2008

2. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers;Gu;Proc. Natl. Acad. Sci.,2008

3. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects;Maeda;Bioconjugate Chem.,2010

4. Cancer nanomedicine: from targeted delivery to combination therapy;Xu;Trends Mol. Med.,2015

5. In vitro and In vivo differences in murine third complement component (C3) opsonization and macrophage/leukocyte responses to antibody-functionalized iron oxide nanoworms;Wang;Front. Immunol.,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles;International Journal of Pharmaceutics;2024-04

2. Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications;Nanoscale;2024

3. Antibodies internalization mechanisms by dendritic cells and their role in therapeutic antibody immunogenicity;European Journal of Immunology;2023-12-03

4. Trastuzumab for Active Targeting in Cancer Therapy;Handbook of Cancer and Immunology;2023-11-16

5. Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells;International Journal of Nanomedicine;2023-11